CDC20 and cancer: To make progress, we are confident that Cdc20-derived peptides, the Tyc1 protein, and the human-derived hp31 peptide can all serve as novel molecular tools to further explore mechanisms for inhibiting the APC/C that give rise to a sensitivity to microtubule poison in vivo as a strategy for targeting cancer cells.